 Connection
Ping-Ching Hsu to Hepatitis B, Chronic
This is a "connection" page, showing publications Ping-Ching Hsu has written about Hepatitis B, Chronic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.712 |
|
|
|
-
Tzeng HT, Tsai HF, Liao HJ, Lin YJ, Chen L, Chen PJ, Hsu PN. PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model. PLoS One. 2012; 7(6):e39179.
Score: 0.397
-
Huang YW, Hsu CK, Lin SC, Wei SC, Hu JT, Chang HY, Liang CW, Chen DS, Chen PJ, Hsu PN, Yang SS, Kao JH. Reduced toll-like receptor 9 expression on peripheral CD14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy. Antivir Ther. 2014; 19(7):637-43.
Score: 0.112
-
Tzeng HT, Hsu PN, Chen PJ. Immunocompetent nontransgenic mouse models for studying hepatitis B virus immune responses. J Gastroenterol Hepatol. 2013 Aug; 28 Suppl 1:116-9.
Score: 0.107
-
Kao JT, Lai HC, Tsai SM, Lin PC, Chuang PH, Yu CJ, Cheng KS, Su WP, Hsu PN, Peng CY, Wu YY. Rather than interleukin-27, interleukin-6 expresses positive correlation with liver severity in na?ve hepatitis B infection patients. Liver Int. 2012 Jul; 32(6):928-36.
Score: 0.096
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|